Neurology

chapter 36 Neurology




HEADACHE


Headache is probably one of the most common reasons for a patient to consult a general practitioner (GP). Many patients are fearful that they may have a serious neurological disorder, such as a brain tumour, whereas in reality this is rare. In primary care, the risk of brain tumour with a headache presentation is less than 0.1%.3 The most common causes of headache seen by a GP are primary headaches such as those associated with fever, tension headache and, less often, migraine. The challenge for the GP is to identify the very rare but more sinister causes of headache, such as subarachnoid haemorrhage (SAH), brain tumour, cranial arteritis, meningitis and so on. There are some clinical features that should increase the suspicion of a secondary cause for headache, such as:







HISTORY


Investigations rarely elucidate the cause of headache; it is the history that is used to determine the aetiology of the headache in the great majority of patients. It has been said that if you only have 30 minutes, spend 29 on the history. Ascertain whether this headache is the first that the patient has experienced or whether it is a recurrent headache; if the latter, ask whether this headache is identical to all the others. If so, it is not unreasonable to treat for that same diagnosis. In patients presenting with new-onset headache, the single most important question is, ‘From the moment you first noticed the headache, how long did it take to reach its maximum severity?’ Headache of sudden onset should be regarded as possible SAH until proved otherwise, although with many of the other causes, sudden-onset headache such as cough, benign sex and exertional headache, there are often other clues to the diagnosis (see below). Ascertain whether there were any associated systemic symptoms such as fever, sweats, anorexia or weight loss, and, in the elderly, the presence of scalp tenderness, jaw claudication of proximal muscle, aches and pains (polymyalgia rheumatica), to alert one to the possibility of infection or cranial arteritis. Headache associated with or exacerbated by particular neck movements may point to a cervicogenic musculoskeletal cause.


In patients with focal neurological symptoms, determine whether these developed suddenly or slowly. If slowly, determine whether there was a cumulative neurological deficit or the focal neurological symptoms evolved gradually, with the latter symptoms appearing after the initial symptoms had either partly or completely resolved—a characteristic of migraine.





MANAGEMENT


Apart from symptomatic relief with analgesia, the management is cause-specific and is discussed below.



Headache of sudden onset









Tension headache and chronic daily headache


This is the most common type of headache encountered by the GP. The headache can be generalised, or focal, unilateral or bilateral. Focal neurological symptoms, nausea and systemic symptoms are absent. The headache typically commences some time after awakening and lasts most of the day, and fluctuation in severity during the day is characteristic. The patient may retire with the headache but usually awakens in the morning free of headache. Chronic daily headache is by definition the presence of headaches on a daily basis for six or more months. Although worsening of daily headache is regarded as a ‘red flag’ for a possible more sinister secondary cause of headache, in fact worsening in terms of increased duration and intensity of headache is not uncommon in these patients, particularly in the setting of increased use of analgesics, a syndrome referred to as the ‘analgesic overuse syndrome’. This is a vicious cycle, where increasing use of analgesics (even aspirin or paracetamol) leads to increasing severe headaches, leading to the use of even more of analgesia. A clue is that the patient often states: ‘I am taking all these pain killers and they do not seem to work any more.’ Many patients also have neck discomfort and when examined may have tenderness in the trapezius and sternocleidomastoid muscles; this often leads to a diagnosis of cervicogenic headache. Here the headache is assumed to be arising from disease in the cervical spine, and yet most patients do not have any demonstrable pathology on imaging or have osteoarthritis that may be an incidental finding, particularly in older patients where it is often present and asymptomatic. Relief of headache can be seen after massage to the neck muscles, physiotherapy or chiropractic, but the benefit may be short-term only.


A multifaceted approach to the treatment of tension-type headache, employing psychological, physiological and pharmacological therapies is recommended.4 The treatment for the analgesic overuse syndrome is for the patient to withdraw analgesia, which they often find difficult. The use of a tricyclic antidepressant for a short period has been shown to be beneficial.5



Migraine


Migraine is a complex headache disorder that has many manifestations. The aetiology is unknown. Patients experience recurrent headaches occasionally associated with recognisable precipitating factors. The diagnosis is entirely dependent on the history of the headache and associated features if present, as currently there are no tests to confirm the diagnosis. The patient with ‘classic migraine’ rarely presents a diagnostic problem. The headache is preceded by visual phenomena or neurological symptoms, referred to as the aura, that commence in one part of the body or visual field and spread, over a period of minutes (on average lasting approximately 30 minutes). The headache is usually throbbing in nature, and commences after the onset of the aura and increases in severity over minutes to hours. It is almost invariably associated with nausea, vomiting, photophobia and phonophobia. The headache persists for hours to days. The associated visual symptoms can vary from photopsia (positive phenomena such as flashing lights or bright dots) to patches of loss of vision, referred to as scotomata, that may or may not be surrounded by positive visual phenomena or fortification spectra. The diagnosis is more difficult in patients with recurrent headaches in which gastrointestinal, visual and neurological symptoms are absent. The diagnosis of probable migraine can be made if the patient experiences recurrent headaches that persist for hours on end and are either present on awakening or awaken the patient from their sleep. Rare forms of migraine include hemiplegic migraine and basilar artery migraine. Some patients can experience the aura of a migraine without the subsequent development of a headache, referred to ‘migraine without headache’ or ‘migraine equivalents’. Migraine headaches that occur only at the time of menstruation are referred to as ‘menstrual migraine’ and are due to the drop in the oestradiol level just prior to menstruation (see ch 52, Gynaecology).


Management consists of treatment for the individual episodes and, in patients with recurrent headaches, recognising and avoiding precipitating factors, and prophylactic medications.


Once a headache has started, rest in a quiet, darkened room and ensure adequate fluid intake. A combination of magnesium, feverfew and riboflavin can be helpful at the onset of a headache. Several well-designed trials support the effectiveness of spinal manipulation therapy in the treatment of migraine headaches.


In essence, treatment consists of selecting a drug with a potential side-effect profile the patient is willing to contemplate, commencing with the smallest possible dose and increasing up to the minimal required or maximal tolerated dose. Often it is a matter of trial and error.


Initial standard medical treatment often consists of simple analgesia, including non-steroidal anti-inflammatory drugs (NSAIDs) with an antiemetic drug such as prochlorperazine or metoclopramide. Ergot preparations, oral, rectal and subcutaneous, or the triptans, have all been shown to be effective.6,7


Prophylaxis for recurrent migraine includes beta-blockers (propanolol, atenolol), tricyclic antidepressants (amitryptiline, nortryptiline), serotonin receptor blockers (pizotifen, methysergide), anticonvulsants (valproic acid, topirimate) or calcium channel blockers (verapamil, flunarazine). Patients are often reluctant to take medication, but may be willing to try a range of integrative medicine approaches.



INTEGRATIVE MANAGEMENT OF HEADACHE/MIGRAINE



Prevention


The goals of prevention are to reduce the frequency, severity and duration of attacks, and to reduce disability.





Herbs and supplements



Magnesium

Intracellular magnesium levels are often lower in people with migraine headaches and magnesium deficiency is common. Two randomised controlled trials (RCTs)8,9 found that high-dose magnesium reduced the frequency and duration of migraine headaches. Magnesium can also help prevent migraine in women with cyclic headaches related to periods, and is also used in treatment of conditions involving muscle spasm or tension, fibromyalgia, anxiety states and tension headaches.





Feverfew (Tanacetum parthenium)

A systematic review of six RCTs11 concluded that evidence favours feverfew as an effective preventative treatment against migraine, and that it is well tolerated. Note that there is significant variation in the amount of active ingredient in commercially available feverfew preparations.



Physical therapies



Chiropractic


In one study12 including 127 people with migraine headaches, 22% of those who received chiropractic manipulation reported more than a 90% reduction of migraines and 49% reported a significant reduction of the intensity of each episode. There is some evidence to suggest that patients with tension headache and headache related to neck pain will benefit from chiropractic, although overall the evidence is less strong that chiropractic is beneficial for migraine.13



Physiotherapy


A review article14 evaluating nine studies that tested spinal manipulative therapy for tension or migraine headaches concluded that this technique is comparable to medications used to try to prevent either of these two types of headaches.



Acupuncture


Acupuncture is well studied as an effective treatment for various types of headache. Results from a study published in 200315 suggest that having an acupuncture treatment when migraine symptoms first begin is as effective as sumatriptan. Later in the course of the migraine attack, however, the medication works better than acupuncture. A 2001 Cochrane review16 found 26 trials on acupuncture for headaches. Of these, 16 trials investigated migraine headaches, six tension-type headaches and four various headaches. The majority, although not all, showed acupuncture to be better than placebo/sham acupuncture for tension/migraine headaches, although the quality of many trials was suboptimal. A more recent literature review by Endres and colleagues17 discussed 10 trials of acupuncture for migraine and concluded that a 6-week course of acupuncture was at least not inferior to a 6-month course of prophylactic treatments, and had a role in the integrated management of migraine headaches.




Trigeminal autonomic cephalalgias


The term ‘trigeminal autonomic cephalalgias’ refers to cluster headaches, chronic paroxysmal hemicrania and SUNCT syndrome.








FUNNY TURNS


Intermittent disturbances of neurological function are a very common problem and the list of potential causes is extensive. This section discusses the more common causes encountered by a GP, including syncope, Stokes-Adams attacks, epilepsy, benign positional vertigo and hyperventilation syndrome.





INVESTIGATIONS


The investigations already alluded to rarely, if ever, establish a diagnosis in patients with intermittent disturbances of function. If seizures are frequent or can be precipitated by sleep deprivation or hyperventilation, then video-electroencephalographic monitoring may occasionally detect a seizure (see Fig 36.2). Holter monitoring can on rare occasions detect complete heart block in patients with suspected Stokes-Adams attacks. Symptoms related to hyponatraemia, hypokalaemia or hypocalcaemia are so rare that routine electrolyte estimation is rarely helpful. A full blood examination could detect anaemia or evidence of an infection, but intermittent symptoms related to either of these entities are very rare. Imaging such as CT scan or MRI scan is usually normal, except for patients with focal seizures.




MANAGEMENT


Management is specifically related to the nature of the disturbance, and is discussed in each section below.





Epilepsy


Epilepsy is the propensity to recurrent seizures. There are many ways to classify seizures, one common way being to divide them into generalised and partial seizures. Generalised seizures include tonic-clonic (previously referred to as grand mal), absence (petit mal), atonic and tonic. Partial seizures include simple (no loss of awareness) and complex (loss of awareness) partial seizures. Some patients experience warning symptoms as the initial manifestation of the seizure, referred to as an aura, and some patients have a period of drowsiness and confusion after the seizure, referred to as post-ictal drowsiness and confusion.







Treatment of seizures and epilepsy


Most seizures last only a matter of 1–2, rarely 5, minutes, and the initial management is simply to prevent the patient from harming themselves and to lie them on their side when the seizure is finished. Prolonged seizures and status epilepsy require prompt intervention. Intravenous (IV) lorazepam is the drug of choice in both adults and children.21


The principles of management of recurrent seizures are to identify potential precipitating factors, prescribe an appropriate anticonvulsant, monitor the response to treatment, and adjust the dose if appropriate or choose an alternative anticonvulsant. Lifestyle advice is crucial in order to prevent the patient harming themselves or others if they suffer recurrent seizures. Such advice should include not swimming or having a bath if alone, not walking near cliffs or scaling heights, and not driving a motor vehicle or industrial machinery. Each country, and often each state, has different regulations and these should be consulted when advising patients of their inability to drive.


Precipitating factors are uncommon but, when they occur, include flashing lights in patients with photosensitive epilepsy, sleep deprivation, excessive alcohol, forgetting medications and an intercurrent illness.


Choosing the correct drug for the individual patient can be complex, and is determined by the type of epilepsy and the side effect profile the patient is willing to contemplate.


Carbamazepine is the drug of choice for partial or focal seizures, and valproic acid for generalised seizures.22 However, carbamazepine interferes with the oral contraceptive pill and causes drowsiness; valproic acid can result in hair loss and obesity, side effects that young women are often not willing to contemplate. There are many guidelines23 and these are frequently evolving and should be consulted on a regular basis.



Integrative management of epilepsy


The adverse effects of antiepileptic pharmaceuticals make it difficult to attain optimal dosage levels in order to prevent seizures in many cases.24 Current evidence suggests that 25–50% of individuals with epilepsy have tried some form of CAM therapy.2527 It is important to note that these therapies are not a substitute for medication; however, depending on the effectiveness of the intervention(s), dosage reductions under medical supervision may be possible.28



Mind–body medicine

A systematic review assessing several different meditative practices (meditation, meditative prayer, yoga, relaxation) has revealed some evidence for the efficacy of meditation in the treatment of epilepsy.29 In particular, studies have demonstrated that transcendental meditation (TM) may be a potential antiepileptic treatment. However, further trials are required, as many of the EEG recordings during TM (increased alpha, theta, gamma frequencies with increased coherence and synchrony) are similar to the neuronal activity that occurs during seizures.30



Sleep

It has long been known that there is a close relationship between the physiological state of sleep and the pathological process underlying epileptic seizures, but the connection is still not well understood.31 Sufferers of epilepsy often demonstrate multiple sleep abnormalities, such as increased sleep latency, fragmented sleep, increased awakenings and stage shifts and an increase in stages 1 and 2 of non-REM sleep.32 It is important that any sleep disorders are identified and managed as soon as possible, as sleep deprivation has been shown to increase the frequency of epileptiform discharges and seizures.3335 Sleep quality, as well as daytime alertness and neurocognitive function, can be improved by anticonvulsant medications, ketogenic dietary principles and vagus nerve stimulation.33 However, it should be noted that poor sleep can also be an adverse effect of some anticonvulsant drugs.24,36




Exercise

In times past, exercise was restricted for those with epilepsy, rather than encouraged, as it is today. As many people with epilepsy still fear suffering an exercise-induced seizure, they often lead a sedentary life and have poor physical fitness.39 Although there have been rare cases of exercise-induced seizures, both clinical and experimental data have shown that exercise can reduce the frequency of seizures as well as improving cardiovascular and psychological health.40,41 Indeed, current evidence demonstrates that regular exercise may have a moderate seizure-preventative effect in 30–40% of this population.39 Most sporting activities, including contact sports, are safe to participate in, according to current medical recommendations. Supervised water sports and swimming are also considered safe, provided seizures are well controlled. However, sports such as hang-gliding and scuba diving are not recommended, as there is a high risk of severe injury or death if a seizure were to occur.40 It is imperative that medical advice regarding exercise is individualised for each patient, taking into account their seizure type and frequency.40



Yoga

Recent studies have shown that yoga can reduce seizure index and increase quality of life in people with epilepsy.42 Yoga has also been shown to significantly improve parasympathetic parameters, suggesting that it may have a role in the treatment of autonomic dysfunction in patients with refractory epilepsy.43



Diet

Maintaining good blood sugar balance, identifying and eliminating allergenic foods and avoiding suspected triggers such as alcohol, artificial sweeteners, diet soft-drinks, energy drinks and MSG are important in the management of epilepsy.28,44,45 Growth retardation is common among children with epilepsy and this appears to be secondary to poor dietary intake. Dietary intake of vitamins D, E and K, folate, calcium, linoleic acid and alpha-linolenic acid has been found to be below the recommended daily allowance (RDA) in approximately 30% of children with intractable epilepsy.46


Studies of dietary treatments for epilepsy suggest that approximately 50% of children have a 50% reduction in seizures after 6 months. Approximately one-third will achieve more than 90% reduction in their seizures. Such diets maintain their efficacy when provided continuously for several years. Furthermore, long-term benefits may be seen even when the diet is ceased after only a few months, indicating neuroprotective effects.47 Other dietary guidelines for the management of epilepsy are given below. Recommending such diets in the management of epilepsy needs to be balanced with the overall nutritional needs and health of the patient.



Ketogenic diet


The ketogenic diet is a high-fat, low-carbohydrate, high-protein diet used to treat medically refractory epilepsy.48 At least 15–20% of patients on the ketogenic diet experience more than 50% reduction in seizure frequency. For this reason, the ketogenic diet should be considered an early treatment for drug-resistant epilepsy, not a ‘last resort’.4951 The ketogenic diet may also be a valuable therapeutic option for children with drug-resistant focal epilepsy, particularly those with recent deterioration of seizure control.52,53





Polyunsaturated fatty acids


Increased concentrations of both ketone bodies and polyunsaturated fatty acids (PUFAs) have been found in the cerebrospinal fluid and plasma of patients on the ketogenic diet, and it is thought that a high dietary intake of PUFAs may be one mechanism responsible for the potent anticonvulsant effects of the ketogenic diet.56,57 Supplementation with omega-3 fatty acids has also been shown to prevent status epilepticus-associated neuropathological changes in animal studies.58 Although PUFAs have been shown to reduce seizures in several animal models, available data regarding the effects of supplementation in epileptic patients (1–3 g EPA/DHA daily) reveal mixed results with respect to seizure frequency.5961 More research is therefore required before PUFAs can be definitively recommended as a treatment option for epilepsy.56





Taurine


Taurine is one of the most abundant free amino acids found mainly in excitable tissues. Taurine is necessary for the production of GABA, one of the major inhibitory neurotransmitters in the limbic system.65 For this reason, drugs that target GABA receptors are the mainstay of treatment of seizures, with the recent transplantation of GABA-producing cells effectively reducing seizures in several well-established models.66,67


There have been multiple animal studies demonstrating that taurine-fed animals have increased levels of GABA and a higher threshold for seizure onset compared to controls.65 Furthermore, increased taurine levels in the hippocampus improve membrane stabilisation, significantly reducing neuronal cell death and favouring recovery after neuronal hyperactivity.68,69




Antioxidants


Excessive production of free radicals with neuronal hyperexcitability have been strongly implicated in the pathogenesis of idiopathic epilepsy. There is therefore a possible role of antioxidants in combination with antiepileptic drugs for better seizure control,7476 although, as with other chronic illnesses, it is likely that a nutritious diet rich in antioxidants such as vitamins A, C and E is likely to be far more effective than a poor diet supplemented by antioxidants. Results have thus far been mixed for vitamin E supplementation, and more studies are required before definitive recommendations can be made.77


Selenium deficiency has been implicated in the pathogenesis of epilepsy.78 Anticonvulsants may further deplete total body selenium stores, and failure to advise appropriate selenium supplementation, especially to pregnant women taking sodium valproate, may increase the risk of neural tube defects or other free radical mediated damage.79




Other vitamins and minerals


Many anticonvulsant medications are known to reduce folic acid levels, subsequently raising homocysteine levels. Homocysteine, however, is known to be a convulsing agent that can result in increased seizure recurrence and intractability to medications. In addition, anticonvulsant medications can disturb lipid metabolism, creating hypercholesterolaemia, dyslipidaemia and altered uric acid metabolism. As such, routine supplementation with folic acid, vitamin B12, B6, C, E and beta-carotene for all those on anticonvulsant medications is important.82


A Cochrane review has found that vitamin B1 improves both neuropsychological and cognitive functions in patients with epilepsy. In the same review, vitamin D was also found to improve bone mineral density in those taking anticonvulsant medications.28,77


Manganese deficiency has also been associated with seizures in both animals and humans, according to a systematic review. More research is needed, as it is currently unclear as to whether this is a cause or an effect of the convulsions.83



Herbs

Herbal medicine has been used for centuries in many cultures for the treatment of epilepsy and some patients may be self-medicating with herbal medicines. It is therefore important for the GP to ask about the patient’s use of herbal preparations, as many herbs can increase the risk of seizures by affecting cytochrome-P450 enzymes and P-glycoproteins, or through possible contamination by heavy metals.84,85


Well-designed clinical trials of herbal therapies for epilepsy are scarce. However, based on animal studies and numerous anecdotal observations of clinical benefits in humans, further research is certainly warranted.84,85


The flavonoid derivatives from Scutellaria baicalensis Georgi, Artemesia herba-alba, Melissa officinalis and Salvia triloba have all been found to exert anticonvulsant effects by exhibiting significant affinity for the GABA(A) receptor benzodiazepine binding site.86,87 Ginkgo biloba appears to have the capacity to both induce and inhibit seizures.88


Interestingly, Curcumin has also recently been shown to significantly prevent generalisation of electroclinical seizure activity as well as the pathogenesis of iron-induced epileptogenesis.89,90 Further studies are required.


Various Chinese herbs, such as Chaihu-longu-muli-tang, appear to have antiepileptic properties, and it also appears that the reduction in seizure frequency may be related to the antioxidant effects of the herbs.91 Shitei-To is another TCM formulation that may have therapeutic effects in the prevention of secondarily generalised seizures. It is made from three medicinal herbs: Shitei (calyx of Diospyros kaki L.f), Shokyu (rhizome of Zingiber officinale Roscoe) and Choji (flower bud of Syzygium aromaticum).92







MOTOR WEAKNESS




EXAMINATION


Central nervous system (CNS) causes of weakness produce a classic ‘upper motor neuron’ pattern of weakness with finger extension, shoulder abduction and elbow extension in the upper limbs and hip flexion, weakness of dorsiflexion of the feet and knee flexion in the lower limbs. This pattern of weakness would most often be associated with increased tone (with or without clonus), increased reflexes and up-going plantar responses. If the facial muscles are affected with CNS, then the forehead is not affected. In disorders of the peripheral nervous system (PNS), the pattern of weakness will indicate whether the problem is in the anterior horn cell (usually associated with significant wasting and fasciculations), motor nerve root (usually associated with significant radicular pain), plexus, peripheral nerve, neuromuscular junction (fluctuating weakness with exercise) or muscle. The presence of sensory signs excludes disorders of the anterior horn cell, motor nerve root, neuromuscular junction or muscle. In disorders of the PNS, the tone may be normal or decreased, the reflexes are often absent, plantar responses are down-going and, if present, sensory signs will reflect the site of the problem in the PNS. Disorders of muscle are usually associated with preserved reflexes (rare exceptions to this include myotonic dystrophy and inclusion body myositis). If the weakness affects the face, it is important to see whether the muscles that wrinkle the forehead (frontalis muscle) are affected; if so, this points to a lower motor neuron facial palsy. If the forehead is not affected but there is weakness around the mouth, this is an upper motor neuron facial weakness.




MANAGEMENT


Management is disease specific and is discussed below.






Facial weakness


The most common cause of an upper motor neuron facial weakness would be cerebral ischaemia on the contralateral side. Bell’s palsy is the most common cause of a lower motor neuron weakness.



Bell’s palsy


Bell’s palsy is an acute, idiopathic, unilateral, lower-motor-neuron facial-nerve paralysis of uncertain aetiology. It is one of the most common ‘urgent’ referrals to a neurologist, because most patients fear that they have suffered a stroke. Patients may often complain of paraesthesia on the face; more often they present with the gradual onset of weakness afflicting one side of the face (bilateral cases are rare but do occur) that develops over hours to days. The inability to wrinkle the forehead on the same side confirms that the weakness relates to a lower motor neuron problem. The presence of hyperacusis in the ipsilateral ear and altered taste on the ipsilateral side of the tongue (related to involvement of the chorda tympani) when present are pathognomonic for Bell’s palsy. Facial and corneal sensation are not affected. The condition resolves spontaneously in more than 80–90% of patients.


Corticosteroids and aciclovir have been recommended in the belief that functional outcome is improved.97 However, a 2009 Cochrane review concluded that corticosteroids and aciclovir have not been proved to be beneficial.98 Subsequent to this review, a large randomised controlled trial99 demonstrated complete recovery at 3 months in 83% of patients treated with prednisolone (50 mg per day for 10 days), as opposed to 63.6% for patients treated with placebo. At 9 months, 94.4% of the prednisolone-treated group had completely resolved, compared to 81.6% for the placebo. No benefit was found from aciclovir.


Other therapies that may be useful for some individuals include relaxation techniques, acupuncture, electrical stimulation, biofeedback training and vitamin therapy (including vitamins B12 and B6, and zinc).



Acute and chronic inflammatory demyelinating neuropathy


The term acute inflammatory demyelinating neuropathy (AIDP) has replaced the term (Landry) Guillain-Barré (Strohl) syndrome. This presents with the rapid onset of weakness usually affecting the limbs, with proximal weakness in the lower limbs and distal weakness in the upper limbs initially, subsequently becoming generalised weakness of the limbs. There is almost invariably neck flexion and occasionally neck extension weakness. The cranial nerves may also be affected, resulting in bilateral facial weakness, palatal weakness or weakness of the extra ocular muscles, resulting in variable patterns including a pseudo-internuclear ophthalmoplegia (INO). The reflexes are absent and there may or may not be peripheral sensory loss. Some patients develop involvement of the autonomic nervous system, resulting in arrythmias, periods of hypertension and hypotension and disturbances of bladder and bowel function. The respiratory muscles are involved in severe cases, and patients will often require long-term ventilation. In addition to supportive measures, either intravenous immunoglobulin (IVIG) or plasma exchange is used in the acute phase.100102 IVIG is probably the treatment modality of choice, for ease of use. The prognosis is variable, with approximately 75% of patients making an excellent recovery; the remainder have mild or moderate impairment, with severe disability occurring in less than 5% of patients.


Chronic inflammatory demyelinating neuropathy (CIDP) can cause the same patterns of weakness as AIDP but evolves more slowly (by definition over more than 6 weeks). IVIG or corticosteroids should be considered in sensory and motor CIDP. IVIG should be considered as the initial treatment in pure motor CIDP.103




Myasthenia gravis


Myasthenia gravis is a very rare autoimmune disease and most GPs are not likely to see a case. The characteristic feature is a weakness that is exacerbated by use of the muscle and reduced in intensity by rest. Myasthenia gravis can remain confined to the extra ocular muscles, where it presents with intermittent ptosis and variable horizontal and vertical diplopia—for example, when reading or watching television. Myasthenia affecting muscles in the rest of the body is referred to as generalised myasthenia. Myasthenia affecting the bulbar musculature (the lower four cranial nerves) will present with dysarthria exacerbated by talking, dysphagia and difficulty chewing, exacerbated by eating. When it affects the muscles of the arms and legs, patients will complain of increasing weakness when they are trying to do activities such as hanging the washing on the line or washing their hair, or they may complain of increased difficulty walking, and of having to rest. The diagnosis can be made at the bedside by asking the patient to repeatedly exercise and by demonstrating increased weakness; or, if it affects the extra ocular muscles, by asking the patient to look up, and observing increased ptosis and the development of increasing diplopia, the longer the patient is looking up. Applying ice to the ptosed eyelid can lead to a dramatic resolution of the ptosis.105 Another bedside test is the Tensilon test, where edrophonium hydrochloride is injected and a transient improvement or resolution of symptoms can be observed. The ice test and the Tensilon test both have a high sensitivity (92–95%) and specificity (97%). Antibodies directed against the acetylcholine receptor (ACHR) are highly specific (98%) but the sensitivity varies from one report to another, from as low as 54% to as high as 88%.106 Electrodiagnostic studies include repetitive nerve stimulation, where a decremental response is observed and the variability of stimulation of the acetylcholine receptor by acetylcholine can be observed with single fibre electromyography (SFEMG)—this is referred to as increased jitter. All patients with myasthenia gravis should have a CT scan of the chest to look for thymic hyperplasia (usually seen in younger patients) or a thymoma (in older patients); these can be either benign or locally malignant. Ocular myasthenia gravis sometimes responds to the cholinesterase inhibitor pyridostigmine.107 Thymectomy is recommended for patients with thymic hyperplasia108 or thymoma.109 IVIG is very effective in the treatment of myasthenic crisis and can be used preoperatively prior to thymectomy or prior to any surgery in patients with generalised myasthenia gravis.101 Corticosteroids, other immunosuppressive agents and plasma exchange are used in patients who fail to respond to thymectomy.110,111

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 3, 2017 | Posted by in GENERAL SURGERY | Comments Off on Neurology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access